Aethlon Medical (AEMD) Reports Q2 Loss of $0.15

Aethlon Medical (NASDAQ: AEMD) reported Q2 EPS of ($0.15), versus ($1.29) reported last year.

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Holcim to acquire Fermacell from James Hardie for EUR 840M